Aurobindo Pharma arm gets marketing nod for Dazublys from European Commission Ruchika Sharma2 July 2025 5:33 PM ISTHyderabad: Aurobindo Pharma has announced that CuraTeQ Biologics, a wholly owned step-down subsidiary of the company, has obtained marketing...
Biocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India Dr. Divya Colin25 Jun 2025 4:51 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control Organisation (CDSCO),...
Biocon, NCSM partner to launch oncology support program Ruchika Sharma24 Jun 2025 10:15 AM ISTThis collaboration combines Biocon's expertise in biosimilars with NCSM's community outreach to enhance cancer care accessibility, affordability in...
EMA Committee recommends EU label update for Roche Phesgo to allow administration outside of clinical settings Ruchika Sharma4 May 2025 1:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive...
Aurobindo Pharma arm CuraTeQ Biologics gets positive opinion for breast cancer drug Dazublys from EMA Ruchika Sharma26 April 2025 11:30 AM ISTHyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the Committee for...
KATHERINE Final Analysis: Trastuzumab Emtansine Superior to Trastuzumab Post-Neoadjuvant Meghna A Singhania29 Jan 2025 5:56 PM ISTAdjuvant T-DM1 significantly improves long-term invasive disease–free and overall survival versus trastuzumab in residual HER2-positive early breast...
Aurobindo Pharma arm gets positive opinion from EMA Committee for Zefylti for neutropenia treatment Ruchika Sharma14 Dec 2024 12:30 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, has announced that the Committee for...
Submit Clinical Data in Indian Subjects: CDSCO Panel Tells AstraZeneca on Trastuzumab deruxtecan Dr. Divya Colin1 Dec 2024 5:30 PM ISTNew Delhi: Responding to the proposal presented by AstraZeneca Pharma India for the approval of additional indication of the drug Trastuzumab...
Reduce price of 3 anti-cancer drugs: Govt asks manufacturers Ruchika Sharma29 Oct 2024 5:46 PM ISTNew Delhi: To ensure the affordable availability of drugs, the government has asked the companies to reduce the prices of three anti-cancer drugs,...
Zydus Lifesciences gets Mexican marketing approval for Mamitra to treat various cancers \ Ruchika Sharma1 Aug 2024 11:46 AM ISTAhmedabad: Zydus Lifesciences Limited has announced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection...
Biocon Biologics, Sandoz Australia ink pact for biosimilars Trastuzumab, Bevacizumab Ruchika Sharma9 Feb 2024 12:30 PM ISTTrastuzumab is a biosimilar of Herceptin and Bevacizumab is a biosimilar of Avastin - both biosimilars are available on the PBS and utilised for the...
Aurobindo Pharma arm bags CDSCO panel recommendation for grant of marketing authorization of biosimilar trastuzumab Ruchika Sharma18 Jan 2024 3:10 PM ISTHyderabad: In a recent BSE filing, Aurobindo Pharma has announced that CuraTeQ Biologics Pvt. Ltd., a wholly owned subsidiary of the...
